MiNK Therapeutics Inc.
INKT | NASDAQ
$12.08
-$0.17 (-1.39%)
Sep 22, 2026, 11:04 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 181.75K | 215.44K | 204.62K | 121.75K | 77.96K | 55.06K |
Gross Profit | -181.75K | -215.44K | -204.62K | -121.75K | -77.96K | -55.06K |
Operating Income | -12.49M | -10.65M | -22.92M | -30.95M | -18.61M | -10.8M |
Interest Income | 180.25K | 172.57K | 463.26K | 253.32K | 2.43K | 2.44K |
Pretax Income | -12.49M | -10.78M | -22.46M | -27.99M | -30.21M | -16.24M |
Net Income | -12.49M | -10.78M | -22.46M | -27.99M | -30.21M | -16.24M |
Selling & General & Admin | 6.73B | 4.1M | 7.43M | 7.71M | 4.56M | 1.23M |
Research & Development | 5.76B | 6.34M | 15.49M | 23.12M | 13.97M | 9.51M |
Other Expenses | -12.47B | n/a | -204.62K | n/a | n/a | n/a |
Operating Expenses | 12.31M | 10.43M | 22.72M | 30.83M | 18.53M | 10.74M |
Interest Expense | n/a | n/a | n/a | 253.32K | 2.43M | 2.44M |
Selling & Marketing Expenses | n/a | -4.31B | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.49M | 10.65M | 22.92M | 30.95M | 18.61M | 10.8M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 4.27M | 3.74M | 3.44M | 3.37M | 3.35M | 3.31M |
Shares Outstanding (Diluted) | 4.27M | 3.86M | 3.44M | 3.37M | 3.35M | 3.31M |
EPS (Basic) | -2.93 | -2.90 | -6.54 | -8.31 | -9.03 | -4.91 |
EPS (Diluted) | -2.93 | -2.80 | -6.54 | -8.31 | -9.03 | -4.91 |
EBITDA | -12.31M | -10.57M | -22.25M | -27.87M | -27.7M | -13.74M |
EBIT | -12.49M | -10.78M | -22.46M | -27.99M | -27.78M | -13.8M |
Depreciation & Amortization | 181.75K | 215.44K | 204.62K | 121.75K | 77.96K | 55.06K |
Add to Watchlist
Select watchlists to add or remove INKT